SnoRNPs, ZNHIT proteins and the R2TP pathway
SnoRNPs, ZNHIT proteins and the R2TP pathway |
https://doi.org/10.18632/oncotarget.6388
Céline Verheggen,
Bérengère Pradet-Balade,
and Edouard Bertrand
|
41399-41400 |
Active transcription without histone modifications
Active transcription without histone modifications |
https://doi.org/10.18632/oncotarget.6437
Sílvia Pérez-Lluch,
Roderic Guigó,
and Montserrat Corominas
|
41401-41401 |
Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex
Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex |
https://doi.org/10.18632/oncotarget.6356
Martin Fischer,
Marianne Quaas,
Annina Nickel,
and Kurt Engeland
|
41402-41417 |
Genome-wide endogenous DAF-16/FOXO recruitment dynamics during lowered insulin signalling in C. elegans
Genome-wide endogenous DAF-16/FOXO recruitment dynamics during lowered insulin signalling in C. elegans |
https://doi.org/10.18632/oncotarget.6282
Neeraj Kumar,
Vaibhav Jain,
Anupama Singh,
Urmila Jagtap,
Sonia Verma,
and Arnab Mukhopadhyay
|
41418-41433 |
LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease
LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease |
https://doi.org/10.18632/oncotarget.5163
Sara Ceccarelli,
Nadia Panera,
Marco Mina,
Daniela Gnani,
Cristiano De Stefanis,
Annalisa Crudele,
Chiara Rychlicki,
Stefania Petrini,
Giovannella Bruscalupi,
Laura Agostinelli,
Laura Stronati,
Salvatore Cucchiara,
Giovanni Musso,
Cesare Furlanello,
Gianluca Svegliati-Baroni,
Valerio Nobili,
and Anna Alisi
|
41434-41452 |
VE1 immunohistochemistry predicts BRAF V600E mutation status and clinical outcome in colorectal cancer
VE1 immunohistochemistry predicts BRAF V600E mutation status and clinical outcome in colorectal cancer |
https://doi.org/10.18632/oncotarget.6162
Christian Schafroth,
José A. Galván,
Irene Centeno,
Viktor H. Koelzer,
Heather E. Dawson,
Lena Sokol,
Gregor Rieger,
Martin D. Berger,
Marion Hädrich,
Robert Rosenberg,
Ulrich Nitsche,
Beat Schnüriger,
Rupert Langer,
Daniel Inderbitzin,
Alessandro Lugli,
and Inti Zlobec
|
41453-41463 |
Identification of cytochrome CYP2E1 as critical mediator of synergistic effects of alcohol and cellular lipid accumulation in hepatocytes in vitro
Identification of cytochrome CYP2E1 as critical mediator of synergistic effects of alcohol and cellular lipid accumulation in hepatocytes in vitro |
https://doi.org/10.18632/oncotarget.6203
Abdo Mahli,
Wolfgang E. Thasler,
Eleonora Patsenker,
Sebastian Müller,
Felix Stickel,
Martina Müller,
Helmut K. Seitz,
Arthur I. Cederbaum,
and Claus Hellerbrand
|
41464-41478 |
Myristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis
Myristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis |
https://doi.org/10.18632/oncotarget.6286
Laura Martínez,
Sandra Torres,
Anna Baulies,
Cristina Alarcón-Vila,
Montserrat Elena,
Gemma Fabriàs,
Josefina Casas,
Joan Caballeria,
Jose C. Fernandez-Checa,
and Carmen García-Ruiz
|
41479-41496 |
Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients
Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients |
https://doi.org/10.18632/oncotarget.6359
Laurence Verneuil,
Christophe Leboeuf,
Guilhem Bousquet,
Charlotte Brugiere,
Morad Elbouchtaoui,
Louis-François Plassa,
Marie-Noelle Peraldi,
Celeste Lebbé,
Philippe Ratajczak,
and Anne Janin
|
41497-41507 |
4-Hydroxynonenal regulates mitochondrial function in human small airway epithelial cells
4-Hydroxynonenal regulates mitochondrial function in human small airway epithelial cells |
https://doi.org/10.18632/oncotarget.6131
Lakshmi Galam,
Athena Failla,
Ramani Soundararajan,
Richard F. Lockey,
and Narasaiah Kolliputi
|
41508-41521 |
Differential role of RIP1 in Smac mimetic-mediated chemosensitization of neuroblastoma cells
Differential role of RIP1 in Smac mimetic-mediated chemosensitization of neuroblastoma cells |
https://doi.org/10.18632/oncotarget.6308
Sebastian Czaplinski,
Behnaz Ahangarian Abhari,
Alica Torkov,
Dominik Seggewiß,
Manuela Hugle,
and Simone Fulda
|
41522-41534 |
Mechanisms for autophagy modulation by isoprenoid biosynthetic pathway inhibitors in multiple myeloma cells
Mechanisms for autophagy modulation by isoprenoid biosynthetic pathway inhibitors in multiple myeloma cells |
https://doi.org/10.18632/oncotarget.6365
Kaitlyn M. Dykstra,
Cheryl Allen,
Ella J. Born,
Huaxiang Tong,
and Sarah A. Holstein
|
41535-41549 |
ASPP1/2-PP1 complexes are required for chromosome segregation and kinetochore-microtubule attachments
ASPP1/2-PP1 complexes are required for chromosome segregation and kinetochore-microtubule attachments |
https://doi.org/10.18632/oncotarget.6355
Pingzhao Zhang,
Yuanyuan Zhang,
Kun Gao,
Yuqi Wang,
Xiaofeng Jin,
Youheng Wei,
Heige Saiyin,
Dejie Wang,
Jintao Peng,
Jian Ma,
Yan Tang,
Reziya Wumaier,
Hongxiu Yu,
Yimin Dong,
Haojie Huang,
Long Yu,
and Chenji Wang
|
41550-41565 |
The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value
The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value |
https://doi.org/10.18632/oncotarget.5893
Pascale A. Cohen,
Caterina F. Donini,
Nhan T. Nguyen,
Hubert Lincet,
and Julie A. Vendrell
|
41566-41581 |
Decoding Warburg’s hypothesis: tumor-related mutations in the mitochondrial respiratory chain
Decoding Warburg’s hypothesis: tumor-related mutations in the mitochondrial respiratory chain |
https://doi.org/10.18632/oncotarget.6057
Jose M. Garcia-Heredia,
and Amancio Carnero
|
41582-41599 |
Concepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapies
Concepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapies |
https://doi.org/10.18632/oncotarget.6113
Simon Gebremeskel,
and Brent Johnston
|
41600-41619 |
MiR224-3p inhibits hypoxia-induced autophagy by targeting autophagy-related genes in human glioblastoma cells
MiR224-3p inhibits hypoxia-induced autophagy by targeting autophagy-related genes in human glioblastoma cells |
https://doi.org/10.18632/oncotarget.5871
Xing Guo,
Hao Xue,
Xiaofan Guo,
Xiao Gao,
Shugang Xu,
Shaofeng Yan,
Xiao Han,
Tong Li,
Jie Shen,
and Gang Li
|
41620-41637 |
MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway
MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway |
https://doi.org/10.18632/oncotarget.5873
Tong Liu,
Kebang Hu,
Zuowei Zhao,
Guanglei Chen,
Xunyan Ou,
Hao Zhang,
Xin Zhang,
Xiaofei Wei,
Dan Wang,
Meizi Cui,
and Caigang Liu
|
41638-41649 |
The proinflammatory LTB4/BLT1 signal axis confers resistance to TGF-β1-induced growth inhibition by targeting Smad3 linker region
The proinflammatory LTB4/BLT1 signal axis confers resistance to TGF-β1-induced growth inhibition by targeting Smad3 linker region |
https://doi.org/10.18632/oncotarget.6146
Woo-Kwang Jeon,
Jiyeon Choi,
Seong Ji Park,
Eun Ji Jo,
Young K. Lee,
Seunghwan Lim,
Jae-Hong Kim,
John J. Letterio,
Fang Liu,
Seong-Jin Kim,
and Byung-Chul Kim
|
41650-41666 |
Eribulin targets a ch-TOG-dependent directed migration of cancer cells
Eribulin targets a ch-TOG-dependent directed migration of cancer cells |
https://doi.org/10.18632/oncotarget.6147
Brice Chanez,
Anthony Gonçalves,
Ali Badache,
and Pascal Verdier-Pinard
|
41667-41678 |
Tristetraprolin induces cell cycle arrest in breast tumor cells through targeting AP-1/c-Jun and NF-κB pathway
Tristetraprolin induces cell cycle arrest in breast tumor cells through targeting AP-1/c-Jun and NF-κB pathway |
https://doi.org/10.18632/oncotarget.6149
Li Xu,
Huan Ning,
Ling Gu,
Qinghong Wang,
Wenbao Lu,
Hui Peng,
Weiguang Cui,
Baoling Ying,
Christina R. Ross,
Gerald M. Wilson,
Lin Wei,
William S.M. Wold,
and Jianguo Liu
|
41679-41691 |
Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2
Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2 |
https://doi.org/10.18632/oncotarget.6150
Min-Che Tung,
Po-Lin Lin,
Yao-Chen Wang,
Tsung-Ying He,
Ming-Ching Lee,
Sauh-Der Yeh,
Chih-Yi Chen,
and Huei Lee
|
41692-41705 |
5-Fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits
5-Fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits |
https://doi.org/10.18632/oncotarget.5991
Corti Denise,
Paolo Paoli,
Maura Calvani,
Maria Letizia Taddei,
Elisa Giannoni,
Scott Kopetz,
Syed Mohammad Ali Kazmi,
Morelli Maria Pia,
Piergiorgio Pettazzoni,
Elena Sacco,
Anna Caselli,
Marco Vanoni,
Matteo Landriscina,
Paolo Cirri,
and Paola Chiarugi
|
41706-41721 |
Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling
Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling |
https://doi.org/10.18632/oncotarget.6152
Wen-Jing Lu,
Mei-Sze Chua,
and Samuel K. So
|
41722-41735 |
A putative biomarker signature for clinically effective AKT inhibition: correlation of in vitro, in vivo and clinical data identifies the importance of modulation of the mTORC1 pathway
A putative biomarker signature for clinically effective AKT inhibition: correlation of in vitro, in vivo and clinical data identifies the importance of modulation of the mTORC1 pathway |
https://doi.org/10.18632/oncotarget.6153
Azadeh Cheraghchi-Bashi,
Christine A. Parker,
Ed Curry,
Jean-Frederic Salazar,
Hatice Gungor,
Azeem Saleem,
Paula Cunnea,
Nona Rama,
Cristian Salinas,
Gordon B. Mills,
Shannon R. Morris,
Rakesh Kumar,
Hani Gabra,
and Euan A. Stronach
|
41736-41749 |
A novel prohibitin-binding compound induces the mitochondrial apoptotic pathway through NOXA and BIM upregulation
A novel prohibitin-binding compound induces the mitochondrial apoptotic pathway through NOXA and BIM upregulation |
https://doi.org/10.18632/oncotarget.6154
Cristina Moncunill-Massaguer,
José Saura-Esteller,
Alba Pérez-Perarnau,
Claudia Mariela Palmeri,
Sonia Núñez-Vázquez,
Ana M. Cosialls,
Diana M. González-Gironès,
Helena Pomares,
Anne Korwitz,
Sara Preciado,
Fernando Albericio,
Rodolfo Lavilla,
Gabriel Pons,
Thomas Langer,
Daniel Iglesias-Serret,
and Joan Gil
|
41750-41765 |
EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC
EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC |
https://doi.org/10.18632/oncotarget.6155
Qijia Yan,
Zhaoyang Zeng,
Zhaojian Gong,
Wenling Zhang,
Xiayu Li,
Baoyu He,
Yali Song,
Qiao Li,
Yong Zeng,
Qianjin Liao,
Pan Chen,
Lei Shi,
Songqing Fan,
Bo Xiang,
Jian Ma,
Ming Zhou,
Xiaoling Li,
Jianbo Yang,
Wei Xiong,
and Guiyuan Li
|
41766-41782 |
Transient receptor potential melastatin 4 channel contributes to migration of androgen-insensitive prostate cancer cells
Transient receptor potential melastatin 4 channel contributes to migration of androgen-insensitive prostate cancer cells |
https://doi.org/10.18632/oncotarget.6157
Christian Holzmann,
Sven Kappel,
Tatiana Kilch,
Marcus Martin Jochum,
Sabine Katharina Urban,
Volker Jung,
Michael Stöckle,
Karen Rother,
Markus Greiner,
and Christine Peinelt
|
41783-41793 |
Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway
Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway |
https://doi.org/10.18632/oncotarget.5993
Ge Qin,
Fei Xu,
Tao Qin,
Qiufan Zheng,
Dingbo Shi,
Wen Xia,
Yun Tian,
Yanlai Tang,
Jingshu Wang,
Xiangshen Xiao,
Wuguo Deng,
and Shusen Wang
|
41794-41808 |
Flavokawain A induces deNEDDylation and Skp2 degradation leading to inhibition of tumorigenesis and cancer progression in the TRAMP transgenic mouse model
Flavokawain A induces deNEDDylation and Skp2 degradation leading to inhibition of tumorigenesis and cancer progression in the TRAMP transgenic mouse model |
https://doi.org/10.18632/oncotarget.6166
Xuesen Li,
Noriko N. Yokoyama,
Saiyang Zhang,
Lina Ding,
Hong-min Liu,
Michael B. Lilly,
Dan Mercola,
and Xiaolin Zi
|
41809-41824 |
Combination of circulating tumor cell enumeration and tumor marker detection in predicting prognosis and treatment effect in metastatic castration-resistant prostate cancer
Combination of circulating tumor cell enumeration and tumor marker detection in predicting prognosis and treatment effect in metastatic castration-resistant prostate cancer |
https://doi.org/10.18632/oncotarget.6167
Kun Chang,
Yun-Yi Kong,
Bo Dai,
Ding-Wei Ye,
Yuan-Yuan Qu,
Yue Wang,
Zhong-Wei Jia,
and Gao-Xiang Li
|
41825-41836 |
Insulin-like growth factor-independent insulin-like growth factor binding protein 3 promotes cell migration and lymph node metastasis of oral squamous cell carcinoma cells by requirement of integrin β1
Insulin-like growth factor-independent insulin-like growth factor binding protein 3 promotes cell migration and lymph node metastasis of oral squamous cell carcinoma cells by requirement of integrin β1 |
https://doi.org/10.18632/oncotarget.5995
Yi-Chen Yen,
Jenn-Ren Hsiao,
Shih Sheng Jiang,
Jeffrey S. Chang,
Ssu-Han Wang,
Ying-Ying Shen,
Chung-Hsing Chen,
I-Shou Chang,
Jang-Yang Chang,
and Ya-Wen Chen
|
41837-41855 |
Adjuvant treatment with tumor-targeting Salmonella typhimurium A1-R reduces recurrence and increases survival after liver metastasis resection in an orthotopic nude mouse model
Adjuvant treatment with tumor-targeting Salmonella typhimurium A1-R reduces recurrence and increases survival after liver metastasis resection in an orthotopic nude mouse model |
https://doi.org/10.18632/oncotarget.6170
Takashi Murakami,
Yukihiko Hiroshima,
Ming Zhao,
Yong Zhang,
Takashi Chishima,
Kuniya Tanaka,
Michael Bouvet,
Itaru Endo,
and Robert M. Hoffman
|
41856-41862 |
Inhibition of iNOS activity enhances the anti-tumor effects of alpha-galactosylceramide in established murine cancer model
Inhibition of iNOS activity enhances the anti-tumor effects of alpha-galactosylceramide in established murine cancer model |
https://doi.org/10.18632/oncotarget.6172
Hiroyasu Ito,
Tatsuya Ando,
and Mitsuru Seishima
|
41863-41874 |
The demographic features, clinicopathologic characteristics, treatment outcome and disease-specific prognostic factors of solitary fibrous tumor: a population-based analysis
The demographic features, clinicopathologic characteristics, treatment outcome and disease-specific prognostic factors of solitary fibrous tumor: a population-based analysis |
https://doi.org/10.18632/oncotarget.6174
Alimujiang Wushou,
Yi-Zhou Jiang,
Yi-Rong Liu,
and Zhi-Ming Shao
|
41875-41883 |
Caveolin-1-negative head and neck squamous cell carcinoma primary tumors display increased epithelial to mesenchymal transition and prometastatic properties
Caveolin-1-negative head and neck squamous cell carcinoma primary tumors display increased epithelial to mesenchymal transition and prometastatic properties |
https://doi.org/10.18632/oncotarget.6099
Alain C. Jung,
Anne-Marie Ray,
Ludivine Ramolu,
Christine Macabre,
Florian Simon,
Fanny Noulet,
Anne-Florence Blandin,
Guillaume Renner,
Maxime Lehmann,
Laurence Choulier,
Horst Kessler,
Joseph Abecassis,
Monique Dontenwill,
and Sophie Martin
|
41884-41901 |
Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL
Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL |
https://doi.org/10.18632/oncotarget.5881
Yoko Hari,
Nanae Harashima,
Yoshitsugu Tajima,
and Mamoru Harada
|
41902-41915 |
GalNAc-T14 promotes metastasis through Wnt dependent HOXB9 expression in lung adenocarcinoma
GalNAc-T14 promotes metastasis through Wnt dependent HOXB9 expression in lung adenocarcinoma |
https://doi.org/10.18632/oncotarget.6019
Ok-Seon Kwon,
Ensel Oh,
Jeong-Rak Park,
Ji-Seon Lee,
Gab-Yong Bae,
Jae-Hyung Koo,
Hyungbum Kim,
Yoon-La Choi,
Young Soo Choi,
Jhingook Kim,
and Hyuk-Jin Cha
|
41916-41928 |
(E)-4-(3-(3,5-dimethoxyphenyl)allyl)-2-methoxyphenol inhibits growth of colon tumors in mice
(E)-4-(3-(3,5-dimethoxyphenyl)allyl)-2-methoxyphenol inhibits growth of colon tumors in mice |
https://doi.org/10.18632/oncotarget.5861
Jie Zheng,
Mi Hee Park,
Dong Ju Son,
Min Gi Choi,
Jeong Soon Choi,
Kyung Tak Nam,
Hae Deun Kim,
Kevin Rodriguez,
Benjamin Gann,
Young Wan Ham,
Sang Bae Han,
and Jin Tae Hong
|
41929-41943 |
STAT3 blockade enhances the efficacy of conventional chemotherapeutic agents by eradicating head neck stemloid cancer cell
STAT3 blockade enhances the efficacy of conventional chemotherapeutic agents by eradicating head neck stemloid cancer cell |
https://doi.org/10.18632/oncotarget.5986
Lin-Lin Bu,
Zhi-Li Zhao,
Jian-Feng Liu,
Si-Rui Ma,
Cong-Fa Huang,
Bing Liu,
Wen-Feng Zhang,
and Zhi-Jun Sun
|
41944-41958 |
Cullin3 promotes breast cancer cells metastasis and epithelial-mesenchymal transition by targeting BRMS1 for degradation
Cullin3 promotes breast cancer cells metastasis and epithelial-mesenchymal transition by targeting BRMS1 for degradation |
https://doi.org/10.18632/oncotarget.5999
Xiongwei Huo,
Suoni Li,
Tingting Shi,
Aili Suo,
Zhiping Ruan,
Hui Guo,
and Yu Yao
|
41959-41975 |
Reciprocal feedback inhibition of the androgen receptor and PI3K as a novel therapy for castrate-sensitive and -resistant prostate cancer
Reciprocal feedback inhibition of the androgen receptor and PI3K as a novel therapy for castrate-sensitive and -resistant prostate cancer |
https://doi.org/10.18632/oncotarget.5659
Wenqing Qi,
Carla Morales,
Laurence S. Cooke,
Benny Johnson,
Bradley Somer,
and Daruka Mahadevan
|
41976-41987 |
Mitochondrial DNA copy number in peripheral blood leukocytes and the aggressiveness of localized prostate cancer
Mitochondrial DNA copy number in peripheral blood leukocytes and the aggressiveness of localized prostate cancer |
https://doi.org/10.18632/oncotarget.5889
Huakang Tu,
Jian Gu,
Qing H. Meng,
Jeri Kim,
John W. Davis,
Yonggang He,
Elizabeth A. Wagar,
Timothy C. Thompson,
Christopher J. Logothetis,
and Xifeng Wu
|
41988-41996 |
Oncogenic Ras suppresses ING4-TDG-Fas axis to promote apoptosis resistance
Oncogenic Ras suppresses ING4-TDG-Fas axis to promote apoptosis resistance |
https://doi.org/10.18632/oncotarget.6015
Jie Sun,
Qi Shen,
Haiqi Lu,
Zhinong Jiang,
Wenxia Xu,
Lifeng Feng,
Ling Li,
Xian Wang,
Xiujun Cai,
and Hongchuan Jin
|
41997-42007 |
Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma
Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma |
https://doi.org/10.18632/oncotarget.5788
Elin S. Gray,
Helen Rizos,
Anna L. Reid,
Suzanah C. Boyd,
Michelle R. Pereira,
Johnny Lo,
Varsha Tembe,
James Freeman,
Jenny H.J. Lee,
Richard A. Scolyer,
Kelvin Siew,
Chris Lomma,
Adam Cooper,
Muhammad A. Khattak,
Tarek M. Meniawy,
Georgina V. Long,
Matteo S. Carlino,
Michael Millward,
and Melanie Ziman
|
42008-42018 |
CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: a systematic review and meta-analysis
CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: a systematic review and meta-analysis |
https://doi.org/10.18632/oncotarget.5714
Li Yiming,
Guo Yunshan,
Ma Bo,
Zang Yu,
Wei Tao,
Liang Gengfang,
Fan Dexian,
Cui Shiqian,
Jiang Jianli,
Tang Juan,
and Chen Zhinan
|
42019-42027 |
Cancer-testis antigen MAGE-C2 binds Rbx1 and inhibits ubiquitin ligase-mediated turnover of cyclin E
Cancer-testis antigen MAGE-C2 binds Rbx1 and inhibits ubiquitin ligase-mediated turnover of cyclin E |
https://doi.org/10.18632/oncotarget.5973
Jiaqing Hao,
Xiao Song,
Jingjing Wang,
Chengli Guo,
Yan Li,
Bing Li,
Yu Zhang,
and Yanhui Yin
|
42028-42039 |
Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma
Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma |
https://doi.org/10.18632/oncotarget.5969
Jiangbo Zhang,
Jin Cheng,
Zhenzhen Zeng,
Yongfeng Wang,
Xiaojun Li,
Qing Xie,
Junqiao Jia,
Ying Yan,
Zhengyang Guo,
Jian Gao,
Mingjie Yao,
Xiangmei Chen,
and Fengmin Lu
|
42040-42052 |
MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: correlation with pathological and clinical data
MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: correlation with pathological and clinical data |
https://doi.org/10.18632/oncotarget.5974
Giulia Pasello,
Loredana Urso,
Manlio Mencoboni,
Federica Grosso,
Giovanni Luca Ceresoli,
Francesca Lunardi,
Stefania Edith Vuljan,
Roberta Bertorelle,
Valeria Sacchetto,
Vincenzo Ciminale,
Federico Rea,
Adolfo Favaretto,
PierFranco Conte,
and Fiorella Calabrese
|
42053-42066 |
PD-1 blockade attenuates immunosuppressive myeloid cells due to inhibition of CD47/SIRPα axis in HPV negative head and neck squamous cell carcinoma
PD-1 blockade attenuates immunosuppressive myeloid cells due to inhibition of CD47/SIRPα axis in HPV negative head and neck squamous cell carcinoma |
https://doi.org/10.18632/oncotarget.5955
Guang-Tao Yu,
Lin-Lin Bu,
Cong-Fa Huang,
Wen-Feng Zhang,
Wan-Jun Chen,
J. Silvio Gutkind,
Ashok B. Kulkarni,
and Zhi-Jun Sun
|
42067-42080 |
Imaging the distribution of an antibody-drug conjugate constituent targeting mesothelin with 89Zr and IRDye 800CW in mice bearing human pancreatic tumor xenografts
Imaging the distribution of an antibody-drug conjugate constituent targeting mesothelin with 89Zr and IRDye 800CW in mice bearing human pancreatic tumor xenografts |
https://doi.org/10.18632/oncotarget.5877
Eva J. ter Weele,
Anton G.T. Terwisscha van Scheltinga,
Jos G.W. Kosterink,
Linda Pot,
Silke R. Vedelaar,
Laetitia E. Lamberts,
Simon P. Williams,
Marjolijn N. Lub-de Hooge,
and Elisabeth G.E. de Vries
|
42081-42090 |
Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model
Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model |
https://doi.org/10.18632/oncotarget.5990
Elisabetta Benedetti,
Andrea Antonosante,
Michele d’Angelo,
Loredana Cristiano,
Renato Galzio,
Damien Destouches,
Tiziana Marilena Florio,
Anne Chloé Dhez,
Carlo Astarita,
Benedetta Cinque,
Alessia Fidoamore,
Floriana Rosati,
Maria Grazia Cifone,
Rodolfo Ippoliti,
Antonio Giordano,
José Courty,
and Annamaria Cimini
|
42091-42104 |
Silencing P2X7 receptor downregulates the expression of TCP-1 involved in lymphoma lymphatic metastasis
Silencing P2X7 receptor downregulates the expression of TCP-1 involved in lymphoma lymphatic metastasis |
https://doi.org/10.18632/oncotarget.5870
Xudong Jiang,
Wenjuan Mao,
Ziyi Yang,
Jia Zeng,
Yi Zhang,
Yang Song,
Ying Kong,
Shuangyi Ren,
and Yunfei Zuo
|
42105-42117 |
LRG1 expression indicates unfavorable clinical outcome in hepatocellular carcinoma
LRG1 expression indicates unfavorable clinical outcome in hepatocellular carcinoma |
https://doi.org/10.18632/oncotarget.5967
Chun-Hua Wang,
Min Li,
Li-Li Liu,
Ruo-Yao Zhou,
Jia Fu,
Chris Zhiyi Zhang,
and Jing-Ping Yun
|
42118-42129 |
Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival
Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival |
https://doi.org/10.18632/oncotarget.6239
Valentina Trimarco,
Elisa Ave,
Monica Facco,
Giorgia Chiodin,
Federica Frezzato,
Veronica Martini,
Cristina Gattazzo,
Federica Lessi,
Carlo Alberto Giorgi,
Andrea Visentin,
Monica Castelli,
Filippo Severin,
Renato Zambello,
Francesco Piazza,
Gianpietro Semenzato,
and Livio Trentin
|
42130-42149 |
Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer
Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer |
https://doi.org/10.18632/oncotarget.6243
Zelai He,
Jingwen Huang,
Yuanyuan Xu,
Xiangyu Zhang,
Yanwei Teng,
Can Huang,
Yufeng Wu,
Xi Zhang,
Huijun Zhang,
and Wenjie Sun
|
42150-42168 |
Correlation of clinical features and genetic profiles of stromal interaction molecule 1 (STIM1) in colorectal cancers
Correlation of clinical features and genetic profiles of stromal interaction molecule 1 (STIM1) in colorectal cancers |
https://doi.org/10.18632/oncotarget.5888
Henry Sung-Ching Wong,
and Wei-Chiao Chang
|
42169-42182 |
Mutant HRAS as novel target for MEK and mTOR inhibitors
Mutant HRAS as novel target for MEK and mTOR inhibitors |
https://doi.org/10.18632/oncotarget.5619
Michael K. Kiessling,
Alessandra Curioni-Fontecedro,
Panagiotis Samaras,
Kirstin Atrott,
Jesus Cosin-Roger,
Silvia Lang,
Michael Scharl,
and Gerhard Rogler
|
42183-42196 |
Sense-antisense gene-pairs in breast cancer and associated pathological pathways
Sense-antisense gene-pairs in breast cancer and associated pathological pathways |
https://doi.org/10.18632/oncotarget.6255
Oleg V. Grinchuk,
Efthymios Motakis,
Surya Pavan Yenamandra,
Ghim Siong Ow,
Piroon Jenjaroenpun,
Zhiqun Tang,
Aliaksandr A. Yarmishyn,
Anna V. Ivshina,
and Vladimir A. Kuznetsov
|
42197-42221 |
New tumor regression grade for rectal cancer after neoadjuvant therapy and radical surgery
New tumor regression grade for rectal cancer after neoadjuvant therapy and radical surgery |
https://doi.org/10.18632/oncotarget.6008
Jun Li,
Hao Liu,
Junjie Hu,
Sai Liu,
Jie Yin,
Feng Du,
Jiatian Yuan,
and Bo Lv
|
42222-42231 |
Combinatorial BTK and MALT1 inhibition augments killing of CD79 mutant diffuse large B cell lymphoma
Combinatorial BTK and MALT1 inhibition augments killing of CD79 mutant diffuse large B cell lymphoma |
https://doi.org/10.18632/oncotarget.6273
Daniel Nagel,
Miriam Bognar,
Andrea C. Eitelhuber,
Kerstin Kutzner,
Michelle Vincendeau,
and Daniel Krappmann
|
42232-42242 |
Molecular characterization of metastatic exon 11 mutant gastrointestinal stromal tumors (GIST) beyond KIT/PDGFRα genotype evaluated by next generation sequencing (NGS)
Molecular characterization of metastatic exon 11 mutant gastrointestinal stromal tumors (GIST) beyond KIT/PDGFRα genotype evaluated by next generation sequencing (NGS) |
https://doi.org/10.18632/oncotarget.6278
Maristella Saponara,
Milena Urbini,
Annalisa Astolfi,
Valentina Indio,
Giorgio Ercolani,
Massimo Del Gaudio,
Donatella Santini,
Maria Giulia Pirini,
Michelangelo Fiorentino,
Margherita Nannini,
Cristian Lolli,
Anna Mandrioli,
Lidia Gatto,
Giovanni Brandi,
Guido Biasco,
Antonio Daniele Pinna,
and Maria Abbondanza Pantaleo
|
42243-42257 |
A Polycomb-mir200 loop regulates clinical outcome in bladder cancer
A Polycomb-mir200 loop regulates clinical outcome in bladder cancer |
https://doi.org/10.18632/oncotarget.5546
Mónica Martínez-Fernández,
Marta Dueñas,
Andrew Feber,
Cristina Segovia,
Ramón García-Escudero,
Carolina Rubio,
Fernando F. López-Calderón,
Claudio Díaz-García,
Felipe Villacampa,
José Duarte,
María J. Gómez-Rodirguez,
Daniel Castellano,
José L. Rodriguez-Peralto,
Federico de la Rosa,
Stephan Beck,
and Jesus M. Paramio
|
42258-42275 |
Involvement of Wnt/β-catenin signaling in the mesenchymal stem cells promote metastatic growth and chemoresistance of cholangiocarcinoma
Involvement of Wnt/β-catenin signaling in the mesenchymal stem cells promote metastatic growth and chemoresistance of cholangiocarcinoma |
https://doi.org/10.18632/oncotarget.5514
Weiwei Wang,
Wei Zhong,
Jiahui Yuan,
Congcong Yan,
Shaoping Hu,
Yinping Tong,
Yubin Mao,
Tianhui Hu,
Bing Zhang,
and Gang Song
|
42276-42289 |
Controllable permeability of blood-brain barrier and reduced brain injury through low-intensity pulsed ultrasound stimulation
Controllable permeability of blood-brain barrier and reduced brain injury through low-intensity pulsed ultrasound stimulation |
https://doi.org/10.18632/oncotarget.5978
Wei-Shen Su,
Min-Lan Tsai,
Sin-Luo Huang,
Shing-Hwa Liu,
and Feng-Yi Yang
|
42290-42299 |
Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia
Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia |
https://doi.org/10.18632/oncotarget.5982
Zheng Ge,
Xing Guo,
Jianyong Li,
Melanie Hartman,
Yuka Imamura Kawasawa,
Sinisa Dovat,
and Chunhua Song
|
42300-42311 |
Germline HOXB13 p.Gly84Glu mutation and cancer susceptibility: a pooled analysis of 25 epidemiological studies with 145,257 participates
Germline HOXB13 p.Gly84Glu mutation and cancer susceptibility: a pooled analysis of 25 epidemiological studies with 145,257 participates |
https://doi.org/10.18632/oncotarget.5994
Qiliang Cai,
Xinpeng Wang,
Xiaodong Li,
Rui Gong,
Xuemei Guo,
Yang Tang,
Kuo Yang,
Yuanjie Niu,
and Yan Zhao
|
42312-42321 |
Fusarochromanone-induced reactive oxygen species results in activation of JNK cascade and cell death by inhibiting protein phosphatases 2A and 5
Fusarochromanone-induced reactive oxygen species results in activation of JNK cascade and cell death by inhibiting protein phosphatases 2A and 5 |
https://doi.org/10.18632/oncotarget.5996
Ying Gu,
Mansoureh Barzegar,
Xin Chen,
Yang Wu,
Chaowei Shang,
Elahe Mahdavian,
Brian A. Salvatore,
Shanxiang Jiang,
and Shile Huang
|
42322-42333 |
Mutational profiling of colorectal cancers with microsatellite instability
Mutational profiling of colorectal cancers with microsatellite instability |
https://doi.org/10.18632/oncotarget.5997
Elaine I. Lin,
Li-Hui Tseng,
Christopher D. Gocke,
Stacy Reil,
Dung T. Le,
Nilofer S. Azad,
and James R. Eshleman
|
42334-42344 |
IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association
IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association |
https://doi.org/10.18632/oncotarget.5645
Houria Debarri,
Delphine Lebon,
Christophe Roumier,
Meyling Cheok,
Alice Marceau-Renaut,
Olivier Nibourel,
Sandrine Geffroy,
Nathalie Helevaut,
Philippe Rousselot,
Bérengère Gruson,
Claude Gardin,
Marie-Lorraine Chretien,
Shéhérazade Sebda,
Martin Figeac,
Céline Berthon,
Bruno Quesnel,
Nicolas Boissel,
Sylvie Castaigne,
Hervé Dombret,
Aline Renneville,
and Claude Preudhomme
|
42345-42353 |
Wait-and-see or radical surgery for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy: a cohort study
Wait-and-see or radical surgery for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy: a cohort study |
https://doi.org/10.18632/oncotarget.6093
Jun Li,
Hao Liu,
Jie Yin,
Sai Liu,
Junjie Hu,
Feng Du,
Jiatian Yuan,
Bo Lv,
Jun Fan,
Shusheng Leng,
and Xin Zhang
|
42354-42361 |
High incidence of MYC and BCL2 abnormalities in mantle cell lymphoma, although only MYC abnormality predicts poor survival
High incidence of MYC and BCL2 abnormalities in mantle cell lymphoma, although only MYC abnormality predicts poor survival |
https://doi.org/10.18632/oncotarget.5705
Shuhua Yi,
Dehui Zou,
Chengwen Li,
Shizhen Zhong,
Weiwei Chen,
Zengjun Li,
Wenjie Xiong,
Wei Liu,
Enbin Liu,
Rui Cui,
Kun Ru,
Peihong Zhang,
Yan Xu,
Gang An,
Rui Lv,
Junyuan Qi,
Jianxiang Wang,
Tao Cheng,
and Lugui Qiu
|
42362-42371 |
Identifying the optimal criteria of radiotherapeutic parameters for patients with unresectable locally advanced hepatocellular carcinoma
Identifying the optimal criteria of radiotherapeutic parameters for patients with unresectable locally advanced hepatocellular carcinoma |
https://doi.org/10.18632/oncotarget.5713
Seok Hyun Son,
Hong Seok Jang,
Soo Yoon Sung,
Hye Jin Kang,
Sojung Lee,
and Chul Seung Kay
|
42372-42379 |
Diffusion kurtosis imaging can efficiently assess the glioma grade and cellular proliferation
Diffusion kurtosis imaging can efficiently assess the glioma grade and cellular proliferation |
https://doi.org/10.18632/oncotarget.5675
Rifeng Jiang,
Jingjing Jiang,
Lingyun Zhao,
Jiaxuan Zhang,
Shun Zhang,
Yihao Yao,
Shiqi Yang,
Jingjing Shi,
Nanxi Shen,
Changliang Su,
Ju Zhang,
and Wenzhen Zhu
|
42380-42393 |